Swift Biosciences specializes in sample preparation for next-generation sequencing (NGS). We are an energetic, highly innovative company focused on creating better tools to empower NGS technologies and deliver superior science. Our products are designed to help customers analyze samples faster, easier, and with greater sensitivity and accuracy while being compatible with leading instrumentation.
Swift's powerful team of scientists and executives have a strong track record of joining discovery with function. Our product development is purposeful and focused on creating products that are well-regarded by both customers and multiple industries, such as the agrigenomics, pharmaceutical, academic, biotechnology, and oncology research fields.
The company was created with the support of experienced life science investors and opened its doors in 2014. Our multiple innovation platforms have been developed by our growing team of talented scientists and are covered by a unique portfolio of intellectual property.
*RUO-For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.
Hoosier Cancer Research Network, Inc., formerly known as Hoosier Oncology Group, is an independent nonprofit contract research organization (CRO) that specializes in early phase multi-center, investigator-initiated oncology clinical trials. Our studies are conducted through a nationwide network of more than 450 academic and community sites. Our highly qualified team provides comprehensive study management including budgeting, contracting, LOI submission, study design, regulatory and IND support, custom EDC development and validation, safety reporting, monitoring, site management, correlative management, data management, and support for publication.
Hoosier Cancer Research Network’s vision and mission is to form unparalleled relationships between academic, community, pharmaceutical, and biotech collaborators with the goal of advancing cancer research, education, and patient advocacy.
Teaming Together To Extend Patients Lives
We are a strategic Contract Research Organization (CRO) running multiple clinical trials in community oncology sites throughout the US. Uniquely focused on community-based hematology & oncology research sites, we provide real-world experience, data and outcomes that lead to improved clinical utility of cancer therapies, improving the lives of cancer patients.
Our full suite of services include expert dedicated project teams, medical writing, data management, analysis and reporting as well as regulatory submissions. Nationally recognized research oncologists and Key Opinion Leaders in the oncology field work in parallel with our senior level clinical research teams. We have an excellent track record of short start-up times and adherence to enrollment and completion timelines.
Our history of client satisfaction and success is the best testimony of our commitment to our clients.
Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.
Pharmaron is a contract research organization (CRO).
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services
CRO - Contract Research Organization
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
in vitro Biology
in vitro Screening
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
in vitro ADME
in vivo PK
Drug Product Manufacturing
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
Microdosing Phase 0
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With more than 28,000 professionals worldwide, PPD has conducted clinical trials in more than 100 countries to help customers deliver life-changing therapies to improve health. We apply innovative technologies, therapeutic expertise and a firm commitment to quality to bend the cost and time curve of drug development and optimize value. For more information, visit www.ppd.com.